Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Terumo BCTbio
With
United States Department of Defense
Radiolabeling of red blood cells (RBCs) followed by infusion back to the donor is commonly used to test the quality of RBCs in a person. By measuring the level of radioisotope in a blood sample, these tests evaluate what percentage of the RBCs remain in the bloodstream after 24 hours (recovery) and can predict how long the RBCs will remain in circulation (survival). The IMPROVE trial is a feasibility trial to evaluate these parameters in RBCs obtained from whole blood units that have been treated with the Mirasol System.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
healthy adults who meet AABB (formerly known as the American Association of Blood Banks) criteria for whole blood donation
females incapable of becoming pregnant
males agreeing to use contraception during trial
You may not be if
pregnancy or nursing
abnormal medical history (bleeding disorders, anemia, myocardial ischemia, uncontrolled hypertension, heart disease, epilepsy)
major surgery
use of drugs affecting coagulation or RBC function
recent participation in other trials which may confound results
